Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies.
Papasavvas E, Lu L, Fair M, Oliva I, Cassel J, Majumdar S, Mounzer K, Kostman JR, Tebas P, Bar-Or A, Muthumani K, Montaner LJ. Papasavvas E, et al. Among authors: muthumani k. bioRxiv [Preprint]. 2024 May 5:2024.05.05.591636. doi: 10.1101/2024.05.05.591636. bioRxiv. 2024. Update in: J Immunol. 2024 Sep 15;213(6):808-822. doi: 10.4049/jimmunol.2400265 PMID: 38746170 Free PMC article. Updated. Preprint.
DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond.
Maslow JN, Kwon I, Kudchodkar SB, Kane D, Tadesse A, Lee H, Park YK, Muthumani K, Roberts CC. Maslow JN, et al. Among authors: muthumani k. Vaccines (Basel). 2023 May 23;11(6):1016. doi: 10.3390/vaccines11061016. Vaccines (Basel). 2023. PMID: 37376404 Free PMC article.
Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost.
Kim WJ, Roberts CC, Song JY, Yoon JG, Seong H, Hyun HJ, Lee H, Gil A, Oh Y, Park JE, Lee JE, Jeon B, Kane D, Spruill S, Kudchodkar SB, Muthumani K, Park YK, Kwon I, Maslow JN. Kim WJ, et al. Among authors: muthumani k. Vaccine. 2023 Jun 29;41(29):4206-4211. doi: 10.1016/j.vaccine.2023.06.013. Epub 2023 Jun 6. Vaccine. 2023. PMID: 37296017 Free PMC article. Clinical Trial.
S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes.
Lin C, Garcia-Gerique L, Bonner EE, Mastio J, Rosenwasser M, Cruz Z, Lawler M, Bernabei L, Muthumani K, Liu Q, Poncz M, Vogl T, Törngren M, Eriksson H, Vogl DT, Gabrilovich DI, Nefedova Y. Lin C, et al. Among authors: muthumani k. Cancer Res Commun. 2023 Mar 13;3(3):420-430. doi: 10.1158/2767-9764.CRC-22-0368. eCollection 2023 Mar. Cancer Res Commun. 2023. PMID: 36923707 Free PMC article.
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P, Adeniji OS, Bordoloi D, Kinslow J, Martinson J, Parent DM, Hong KY, Koshy J, Kulkarni AJ, Zilberstein NF, Balk RA, Moy JN, Giron LB, Tracy RP, Keshavarzian A, Muthumani K, Landay A, Weiner DB, Abdel-Mohsen M. Saini P, et al. Among authors: muthumani k. mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2. mBio. 2023. PMID: 36728420 Free PMC article.
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
Kim WJ, Roberts CC, Song JY, Yoon JG, Seong H, Hyun HJ, Lee H, Gil A, Oh Y, Park JE, Jeon B, Lee JE, Choi SK, Yoon SK, Lee S, Kim B, Kane D, Spruill S, Kudchodkar SB, Muthumani K, Park YK, Kwon I, Jeong M, Maslow JN. Kim WJ, et al. Among authors: muthumani k. Int J Infect Dis. 2023 Mar;128:112-120. doi: 10.1016/j.ijid.2022.12.037. Epub 2022 Dec 31. Int J Infect Dis. 2023. PMID: 36592685 Free PMC article.
131 results